• Study of lidocaine hydrochloride, ropivacaine, and sodium chloride on acute pain in healthy adults aged 18‑64

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Norway
  • ELV001 for Active Rheumatoid Arthritis in Patients with Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition

    Not yet recruiting

    2 1
    Investigated diseases:
    Bulgaria Czechia Hungary The Netherlands Poland Spain
  • Duchenne Muscular Dystrophy in Patients with Gene Mutations Amenable to Exon 44 Skipping Treated with Delpacibart Zotadirsen

    Not yet recruiting

    3 1
    Investigated diseases:
    Belgium France Germany Italy The Netherlands Poland +1
  • INCA33890 With Standard Chemotherapy and Bevacizumab in First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Austria Belgium Denmark France Germany Italy +4
  • Asthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate

    Not yet recruiting

    3 1 1 1
    Bulgaria France Germany Italy Poland Romania +2
  • Efficacy and safety of GB-0895 as adjunctive therapy in adults and adolescents with severe uncontrolled asthma (randomized, placebo‑controlled)

    Not yet recruiting

    3 1
    Investigated diseases:
    Belgium France Ireland Italy Slovakia Spain
  • Obrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium Czechia Denmark Finland France +8
  • Long‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis

    Not yet recruiting

    2 1 1
    Bulgaria Czechia France Hungary Italy Poland +3
  • Phase I/II study of DJI136 with drug combination in adult patients with extensive-stage small cell lung cancer

    Not yet recruiting

    2 1 1 1
    France Spain
  • EIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Germany Greece Italy The Netherlands Romania Spain

powered by